iSpecimen Inc. (ISPC)
| Market Cap | 4.92M |
| Revenue (ttm) | 10.31M |
| Net Income (ttm) | -10.19M |
| Shares Out | 9.08M |
| EPS (ttm) | -1.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 19,109 |
| Open | 0.540 |
| Previous Close | 0.560 |
| Day's Range | 0.540 - 0.590 |
| 52-Week Range | 0.407 - 2.046 |
| Beta | 2.13 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 2, 2023 |
About ISPC
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access... [Read more]
Financial Performance
In 2022, iSpecimen's revenue was $10.40 million, a decrease of -6.58% compared to the previous year's $11.14 million. Losses were -$10.25 million, 14.3% more than in 2021.
Financial StatementsNews
iSpecimen Reports Third Quarter 2023 Financial and Operating Results
Sequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business Initiatives Sequential Quarterly Revenue Growth of 75% Drive...
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease Research
New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom Projects New Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Comple...
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially
Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023 Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen Providers
Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical Research Accurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Med...
iSpecimen Expands Provider Network to Enhance Support for Women's Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIs ...
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive Profitability
Company to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense Reductions Company to Focus on Core Revenue Drivers, New Re...
Top 5 Health Care Stocks That May Explode In Q3 - BioVie (NASDAQ:BIVI), Galera Therapeutics (NASDAQ:GRTX)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
iSpecimen Launches New Virtual Cancer Sequencing Procurement Program
Program to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutati...
iSpecimen Enhances Proprietary Marketplace Platform to Streamline Biospecimen Matchmaking for Researchers and Providers
New Capabilities Enable Platform to Efficiently Collect and Store Most Up-to-Date Data from Providers and Facilitate Automated, Instant Matchmaking for Researcher Requests New Capabilities Enable Plat...
iSpecimen Introduces New Marketplace Functionality to Streamline Access to Clinical Remnant Samples for Researchers
Company Continues to Enhance the Biospecimen Procurement Process and Provide Increasingly Robust Specimen and Patient Data Company Continues to Enhance the Biospecimen Procurement Process and Provide ...
iSpecimen Reports Second Quarter 2023 Financial and Operating Results
LEXINGTON, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medi...
iSpecimen to Report Second Quarter 2023 Results on August 2, 2023
LEXINGTON, Mass., July 25, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medi...
Thirteen New Biospecimen Suppliers Added to iSpecimen's Proprietary Provider Network
Network's Expansion Across the U.S. and Europe Aims to Advance Translational Genomics Research Network's Expansion Across the U.S. and Europe Aims to Advance Translational Genomics Research
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on June 1, 2023
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen”), an online global marketplace that connects scientists requiring biospecimens for medical research with ...
iSpecimen Reports First Quarter 2023 Results
LEXINGTON, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medica...
iSpecimen to Participate in the Aegis Virtual Conference on May 4, 2023
LEXINGTON, Mass., April 24, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for me...
iSpecimen to Report First Quarter 2023 Results on May 4, 2023
LEXINGTON, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for med...
iSpecimen Reports Full Year 2022 Results
- Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year - - Reported Record Quarterly Revenue of $3.2 Million, Up 28% Year-Over-Year -
iSpecimen to Report Fourth Quarter and Full Year 2022 Results on March 14, 2023
LEXINGTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medi...
iSpecimen Expands Biospecimen Provider Network
iSpecimen Strategically Grows its Proprietary Marketplace Platform with Seven New Biospecimen Sample Providers Across the U.S. and Europe iSpecimen Strategically Grows its Proprietary Marketplace Plat...
iSpecimen Appoints Eric Langlois as Chief Revenue Officer
Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth During His Tenure as the Company's Former SVP of Sales and Business Development Mr. Langlois Led iSpecimen to 3,000 Percent Revenue Growth Du...
iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medi...
iSpecimen to Participate in Maxim's Healthcare IT Virtual Conference on January 25, 2023
LEXINGTON, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medi...
iSpecimen Names Tracy Curley as Chief Executive Officer
Previously Appointed Interim CEO in September 2022 Previously Appointed Interim CEO in September 2022
iSpecimen Appoints Joseph J. Basile to Board of Directors
Sought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Restructuring and Governance to iSpecimen Sought-After Strategic Advisor Brings Expertise in Mergers and Acquisitions, Rest...